Jobs
-
MAP Pharmaceuticals has hired Frederick H. Graff as VP, Commercial Operations, a position newly created in anticipation of a potential launch of the company’s Levadex inhaled dihydroergotamine (DHE) for the treatment of migraine. Graff was… Read more . . .
-
On or about September 6, 2011, United States District Court Judge William G. Young will hold a hearing to issue sanctions against InnovaSystems for contempt of court, having ruled that Innova has violated a permanent… Read more . . .
-
The US FDA has accepted the new drug application (NDA) filed by Teva on May 24, 2011 for its beclomethasone dipropionate (BDP) hydrofluoroalkane nasal spray for the treatment of seasonal allergic rhinitis (SAR) and perennial… Read more . . .
-
According to news reports, the US Federal Bureau of Investigation (FBI) has raided the San Diego, California headquarters of vaccine developer NexBio and removed papers. FBI agent Darrell Foxworth is quoted as saying that the… Read more . . .
-
Ten slots available for posters, with the top three posters chosen for a Posters on Podium session. Abstracts should be submitted by August 17, 2011 to Sai Prasanth Chamarthy or Jason Ehrick, co-chairs of the… Read more . . .
-
Two days after announcing that it had licensed VR315 in the US to an undisclosed pharmaceutical company, Vectura announced that Sandoz has licensed the product in the rest of the world. Sandoz already has an… Read more . . .
-
Finnish pharmaceutical company Orion Corporation will co-market combination products delivered by its Easyhaler dry powder inhaler with Nycomed. The agreement covers major European countries, the Middle East, and North Africa. Orion will manufacture the products… Read more . . .
-
University of Michigan spin-off NanoBio has licensed a novel respiratory syncytial virus (RSV) from the US National Institutes of Health (NIH). NIH developed the antigen using proprietary technology. No approved vaccine for RSV currently exists;… Read more . . .
-
Vectura is not saying which international pharmaceutical company’s US division has entered into a “collaboration, development, and license agreement” for the VR315 dry powder inhaler. VR315 is a fixed dose combination therapy for asthma and… Read more . . .
-
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is warning consumers against using a “fake tan nasal spray” marketed as Ubertan. According to the agency, the product comes in two versions, one of which… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland